[Abstract] The spatiotemporal localization of different intracellular factors in real-time and their detection in live cells are important parameters to understand dynamic protein-based processes. Therefore, there is a demand to perform live-cell imaging and to measure endogenous protein dynamics in single cells.
www.bio-protocol.org/e3069 www.bio-protocol.org/e3069 2. Let cells re-attach to the coverslip surface overnight.
3. Pre-warm 4% PFA, diluted in PBS to 37 °C in a water bath.
4. Remove growth medium from the cells and rinse them twice with PBS.
5. Fix the cells by adding the pre-warmed 4% PFA for 5 min at RT.
6. Rinse the cells two times with PBS.
7. Permeabilize the cells by incubating them in PBS containing 0.1% Triton X-100 for 20 min at RT. in 10% FCS in PBS for 1 h at RT.
13. Repeat the wash-steps as mentioned in Steps A10 and A11.
14. Mount the coverslip on a microscope slide using 6-10 μl of Vectashield mounting medium containing DAPI.
15. Observe your cells under the microscope to define if the antibody shows the expected staining of the target (see Figure 1 and Note 2). B. Purification of mouse monoclonal antibodies for electroporation (see Figure 2A ) 5. Remove all PBS from the beads and add 2 ml of antibody solution with a concentration of around 1 mg/ml to the beads.
6. Incubate the beads for 2 h at 4 °C under constant shaking.
7. Centrifuge the beads for 5 min at 277 x g at 4 °C.
8. Remove the supernatant and keep it on ice. This is the flow through (FT) which shouldn't contain any antibodies anymore.
9. Add 2 ml of PBS to the beads, resuspend them and transfer them to a Poly-Prep chromatography column.
10. Add a total of 20 ml of PBS to wash the beads and to remove all unspecific bound proteins.
11. Prepare ten 1.5 ml Eppendorf tubes with 70 μl of 1 M Tris-HCl pH 8.2 for fractionation and neutralization.
12. After all the PBS passed through the column, start the elution of the antibody from the beads by adding stepwise 10 ml of 0.1 M glycine-HCl pH 2.7 in 1 ml steps and collect the fractions in the prepared Eppendorf tubes containing the neutralization buffer.
13. Analyze an aliquot of every elution fraction by SDS-PAGE using a 12% SDS-acrylamide gel. 15. Dialyze the pooled fractions against a total of 4 L of PBS in two steps using DiaEasy dialyzer tubes, the first step overnight and the second for 4 h with 2 L of PBS each at 4 °C.
16. Measure the concentration of the dialyzed antibody by 280 nm absorption and an extinction coefficient of 1.37 using a NanoDrop spectrophotometer. Concentrate the purified antibodies using the 4 ml Amicon filter units with a cutoff of 10 kDa by centrifugation at 4,000 x g until the concentration is 1 mg/ml or higher. 4. Use an Eppendorf magnetic stand to fix the magnetic beads and remove the storage solution.
5. Wash the beads 3 x each with 300 μl of PBS by resuspending them in the buffer and afterwards removing the washing buffer again with the help of the magnet.
6. Remove all PBS and add the antibody solution with TCEP to the beads.
7. Incubate for 3 h at 37 °C under shaking.
8. Remove and collect the supernatant (S1) from the beads using the magnet (this includes the Fab's).
9. Wash the beads again 3 x with PBS and store them at 4 °C in PBS to be able to reuse them.
10. For the purification of the Fab fragments, transfer 100 μl of Protein A Sepharose beads into a 0.5 ml Eppendorf tube.
11. Equilibrate the beads by washing them 4 x each with 300 μl of PBS. Centrifuge them for each wash-step for 3 min at 277 x g.
12.
Remove all PBS and add supernatant (S1) from the digestion to the beads.
13. Incubate for 30 min at 4 °C under shaking.
14. Centrifuge for 5 min at 277 x g and collect the supernatant (S2).
15. Wash beads with 300 μl of PBS and centrifuge again.
16. Collect wash step and pool with supernatant (S2).
17. Concentrate the fraction S2 using an Amicon filter unit with a cutoff of 10 kDa (0.5 ml or 4 ml tubes) to about 100 μl volume (5 min at 14,000 x g). This is now fraction S3.
18. Determine the concentration of the Fab by measuring the absorption at 280 nm and an extinction coefficient of 1.37 using the NanoDrop spectrophotometer.
19. Perform an SDS-PAGE using a 4%-15% acrylamide gradient gel and 1 µl of each of the following samples that need to be boiled for 5 min before loading:
Input antibody solution Supernatant S1
Supernatant S2 Supernatant S3
Filtrate from the Amicon concentration step 20. The Fab fragments are now purified and ready for labeling. 4. Remove non-bound dyes by purifying the labeling mix using the gel filtration columns supplied in the labeling kit.
Note: Washing of the gel filtration column with PBS prior to loading of the labeling reaction is
recommended as it will remove any traces of NaN3 that is present in the storage buffer of the gel filtration beads.
5. Concentrate the labeled antibody/Fab by using 0.5 ml Amicon filter units with a cut-off of 10 kDa.
Centrifuge for 10 min at 14,000 x g to concentrate the solution to a volume of approximately 50 μl.
6. Measure the concentration of the labeled antibody using a NanoDrop spectrophotometer and the Protein and Labels mode.
7. Labeling efficiency can be visualized by SDS-PAGE and UV illumination (see Figure 2B ) and quantified by measuring the absorption at 280 nm and at the dye specific wavelength. The dye/antibody labeling ratio can then be calculated using the formula mentioned in the protocol of Invitrogen. 6. Remove the growth medium and resuspend the cell pellet in 4 ml of PBS and centrifuge them again.
7. Remove the PBS and resuspend the pellet in 80 μl of resuspension buffer (R-buffer).
Note: As soon as the cells are resuspended in R-buffer, it is important to proceed quickly to the

electroporation. Cell viability could decrease significantly if the cells remain longer than 15 min in R-buffer. The resuspension buffer (R-buffer) is part of the electroporation kit from Invitrogen
and therefore its composition is confidential. However, we also tested 250 mM sucrose buffer in 1x PBS (Brees and Fransen, 2014) or just simple 1x PBS and they also worked for the electroporation of antibodies.
Mix 10 μl of the resuspended cells with the antibody/Fab solution and pipette this mix with the
Neon pipette using the 10 μl Neon tips. Be careful that no bubble can be seen in the Neon tip as this will induce an electric short-circuit which will kill the cells during the electroporation. 13. The same protocol as in Procedure A can be followed if the cells need to be fixed starting with
Step A3 but except that for the electroporation of labeled antibodies/Fabs Steps A6-A12 can be skipped.
14. For live-cell imaging, the samples can be observed under the microscope after the incubation time (see Figure 3) . and specific nuclear staining for RPB1 can be observed. D. U2OS cells were electroporated with an antibody against MBP (maltose binding protein), which is not present in human cells.
The cells were fixed 24 h after electroporation and the localization of the antibody was visualized using confocal microscopy. Even after 24 h, the antibody stays in the cytoplasm as it has no target protein for the transport into the nucleus. Scale bars = 10 μm.
Data analysis
1. The microscopes used for the analysis were either confocal, spinning disk or 3D-SIM superresolution microscopes for live-imaging or fixed cell acquisition. For each electroporation experiment, we perform at least three replicates. All samples for one data set were acquired on the same day with the same microscope settings. The use of higher laser power or longer exposure times for these samples is completely normal as labeling of endogenous proteins always results in lower signal intensities. The laser power and exposure times can vary from 5%
to 20% or 40 ms to 200 ms respectively depending on the labeling efficiency, target protein as well as the microscope used.
2. Microscopic analysis of electroporated cells should be performed within 3 days after transduction. The fluorescent signal intensity will decrease significantly due to degradation of the antibody/Fab or by dilution due to cell division. This loss of signal is a general observation for all antibodies and Fabs and can vary depending on the division rate of the cell line used. The U2OS cells used in this protocol for example, are dividing every 24 h. Thus, almost half of the fluorescent signal is lost after each cell division (see Figure 4 ).
3. Bright spots eventually present in the cytoplasm of cells after electroporation may correspond to antibodies that were structurally altered due to dye conjugation and they thus tend to aggregate in the cytoplasm. A possibility to avoid the formation of these aggregates is to electroporate a lesser amount of antibodies/Fabs or to repeat the labeling experiment using less dye.
4. For fixed cell analysis, it is possible that bright spots can be detected on the coverslip outside of the cells. These spots most probably correspond to unbound fluorescent antibodies which were washed out of the cells during the fixation process. Wrong storage of the labeled antibodies can increase the amounts of these artifact spots (see Note below for storage information).
However, most of these spots will be removed during the washing steps after fixation using the wash buffer including Triton X-100. same data set, the image processing should be performed in the same way.
6. It is recommended to perform validation experiments for cell viability and function every time a new antibody/Fab is used for electroporation. Apoptosis and proliferation assays should be performed to test for antibody toxicity. Also, specific validation tests concerning the mechanism involving the target protein inside the cell should be performed to ensure that the antibody is not inhibiting any important function of the protein (e.g., measuring the amount for nascent RNA transcription for a target involved in transcription). 3. Full-length antibodies are too big to be able to diffuse freely into the nucleus. They need to bind to the newly synthesized target protein in the cytoplasm and get piggybacked with it into the nucleus. Therefore, the time for the transport of the antibody into the nucleus depends highly on the turnover of the target protein and antibodies (see Figure 3D ). Note that full-length antibodies against posttranslational modifications in the nucleus will never reach their target and will remain cytoplasmic. In contrast, Fab fragments can diffuse freely into the nucleus and are particularly adapted to target posttranscriptional modifications or proteins with a low cellular turnover.
4. To test if the antibody or Fab is functional inside the cell, it is recommended to electroporate them once before they get fluorescently labeled. They can be visualized after fixation with a fluorescently labeled secondary antibody.
5. To test a new antibody or Fab it is also important to verify how much antibody is needed to be electroporated to bind and label all of the target protein in the cell. Therefore, for the first electroporation, a titration experiment with different amounts of antibodies or Fabs in a range between 1-5 μg is recommended. Antibody amounts higher than 10 μg should be avoided as these high amounts of protein electroporated will start to get toxic for the cell. 
